HPV Vaccination for MSM: Synthesis of the evidence and recommendations from the Québec Immunization Committee

Diseases associated with the human papilloma virus (HPV) are particularly common among men who have sex with men (MSM). Unlike heterosexual men, MSM do not benefit from the herd protection provided by the vaccination of girls. In this review, we synthesize the available evidence on HPV vaccination f...

Full description

Saved in:
Bibliographic Details
Published in:Human vaccines & immunotherapeutics 2016-06, Vol.12 (6), p.1560-1565
Main Authors: Sauvageau, Chantal, Dufour-Turbis, Christine
Format: Article
Language:eng
Subjects:
HPV
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Diseases associated with the human papilloma virus (HPV) are particularly common among men who have sex with men (MSM). Unlike heterosexual men, MSM do not benefit from the herd protection provided by the vaccination of girls. In this review, we synthesize the available evidence on HPV vaccination for MSM. We also present the recommendations of the Québec Immunization Committee (CIQ) in this regard, which are: to provide targeted vaccination for MSM up to 26 years of age and in-school vaccination of preadolescent boys since this is the best approach to take to have a real impact on the burden related to HPV in the MSM population and to provide direct protection for all men.
ISSN:2164-5515
2164-554X